Affordable Combinations in T2DM care: Scope of Glipizide, Metformin and Glimepiride, Metformin, Pioglitazone
Written By : Dr. Nandita Mohan
Published On 2024-05-20 06:01 GMT | Update On 2024-06-10 09:53 GMT
Advertisement
Dual therapy of Glipizide + Metformin and the triple drug combination of Glimepiride + Metformin + Pioglitazone emerges as effective, safe, and affordable options for achieving glycemic control in the management of type 2 diabetes mellitus (T2DM), a latest review article concluded.
This article authored by Indian doctors has been published in the May 2024 edition of Cureus, a wing of the Springer Nature Journal.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.